Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis.

× No keyword cloud information.

6 in total

1. Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment.

Authors: Maria G Tektonidou; John Serelis; Fotini N Skopouli
Journal: Clin Rheumatol Date: 2006-07-06 Impact factor: 2.980

2. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.

Authors: K Selmaj; C S Raine; A H Cross
Journal: Ann Neurol Date: 1991-11 Impact factor: 10.422

3. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.

Authors:
Journal: Neurology Date: 1999-08-11 Impact factor: 9.910

4. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

Authors: N Mohan; E T Edwards; T R Cupps; P J Oliverio; G Sandberg; H Crayton; J R Richert; J N Siegel
Journal: Arthritis Rheum Date: 2001-12

5. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis.

Authors: M K Sharief; R Hentges
Journal: N Engl J Med Date: 1991-08-15 Impact factor: 91.245

6. Tumor necrosis factor identified in multiple sclerosis brain.

Authors: F M Hofman; D R Hinton; K Johnson; J E Merrill
Journal: J Exp Med Date: 1989-08-01 Impact factor: 14.307

6 in total

10 in total

1. A case of spontaneously recovering multifocal motor neuropathy with conduction blocks (MMNCB) during anti-TNF alpha therapy for ankylosing spondylitis.

Authors: Giuseppe Paolazzi; Susanna Peccatori; Francesco P Cavatorta; Alberto Morini
Journal: Clin Rheumatol Date: 2009-04-07 Impact factor: 2.980

2. Letters to the Editor.

Authors:
Journal: Ochsner J Date: 2017

3. Investigation of effects of two-different treatment modalities on nerve conduction in patients with ankylosing spondylitis.

Authors: Erhan Capkin; Murat Karkucak; Muammer Muslim Kose; Vildan Altunayoğlu Çakmak; Aysegul Kucukali Turkyilmaz; Mehmet Tosun
Journal: Rheumatol Int Date: 2010-12-01 Impact factor: 2.631

4. Rheumatoid meningitis associated with infliximab.

Authors: Susan Seago; Edana Stroberg; Austin Metting
Journal: Proc (Bayl Univ Med Cent) Date: 2016-04

5. Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?

Authors: Eugeniusz Józef Kucharz; Anna Kotulska-Kucharz
Journal: Reumatologia Date: 2021-04-27

Review 6. The rheumatoid hand in the light of fluorescence: a diagnostic technique of the future?

Authors: Paweł Żuchowski; Marzena Waszczak-Jeka; Szymon Kudlicki; Sławomir Jeka
Journal: Reumatologia Date: 2019-02-28

Review 7. Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis.

Authors: Przemysław J Kotyla; Md Asiful Islam; Małgorzata Engelmann
Journal: Int J Mol Sci Date: 2020-10-07 Impact factor: 5.923

Review 8. Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?

Authors: Przemysław J Kotyla; Małgorzata Engelmann; Joanna Giemza-Stokłosa; Bartosz Wnuk; Md Asiful Islam
Journal: Int J Mol Sci Date: 2021-02-28 Impact factor: 5.923

Review 9. Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus.

Authors: Przemysław Kotyla; Olga Gumkowska-Sroka; Bartosz Wnuk; Kacper Kotyla
Journal: Pharmaceuticals (Basel) Date: 2022-07-28

Review 10. Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?

Authors: Przemyslaw J Kotyla
Journal: Int J Mol Sci Date: 2018-06-12 Impact factor: 5.923

10 in total